AAAAAA

   
Results: 1-7 |
Results: 7
MS-CANE - COMPUTER-AIDED NEUROLOGICAL EVALUATION OF MULTIPLE-SCLEROSIS PATIENTS, BASED ON KURTZKES EXPANDED DISABILITY STATUS SCALE
Authors: COHEN YC HASSINBAER S BARISHEV R GOLDHAMMER Y MOSES B
Citation: Yc. Cohen et al., MS-CANE - COMPUTER-AIDED NEUROLOGICAL EVALUATION OF MULTIPLE-SCLEROSIS PATIENTS, BASED ON KURTZKES EXPANDED DISABILITY STATUS SCALE, Neurology, 50(4), 1998, pp. 4040-4040
INTRAVENOUS IMMUNOGLOBULIN TREATMENT IN MULTIPLE-SCLEROSIS - EFFECT ON RELAPSES
Authors: ACHIRON A GABBAY U GILAD R HASSINBAER S BARAK Y GORNISH M ELIZUR A GOLDHAMMER Y SAROVAPINHAS I
Citation: A. Achiron et al., INTRAVENOUS IMMUNOGLOBULIN TREATMENT IN MULTIPLE-SCLEROSIS - EFFECT ON RELAPSES, Neurology, 50(2), 1998, pp. 398-402
EVIDENCE FOR GENETIC-HETEROGENEITY SUPPORTS CLINICAL DIFFERENCES IN CONGENITAL MYASTHENIC SYNDROMES
Authors: MENOLD MM SADEH M LENNON F BLATT I GOLDHAMMER Y YAMAOKA LH VANCE JM PERICAKVANCE MA
Citation: Mm. Menold et al., EVIDENCE FOR GENETIC-HETEROGENEITY SUPPORTS CLINICAL DIFFERENCES IN CONGENITAL MYASTHENIC SYNDROMES, Human heredity, 48(6), 1998, pp. 325-332
EVIDENCE FOR GENETIC-HETEROGENEITY SUPPORTS CLINICAL DIFFERENCES IN CONGENITAL MYASTHENIC SYNDROMES (CMS)
Authors: MENOLD MM LENNON F SADEH M GOLDHAMMER Y BLATT I YAMAOKA LH VANCE JM PERICAKVANCE MA
Citation: Mm. Menold et al., EVIDENCE FOR GENETIC-HETEROGENEITY SUPPORTS CLINICAL DIFFERENCES IN CONGENITAL MYASTHENIC SYNDROMES (CMS), American journal of human genetics, 61(4), 1997, pp. 1667-1667
NEUROPSYCHIATRIC ASSESSMENT AS A SECONDARY OUTCOME MEASURE IN A MULTIPLE-SCLEROSIS IVIG TRIAL
Authors: BARAK Y ACHIRON A GABBAY U GILAD R SAROVAPINHAS I GOLDHAMMER Y GORNISH M NOY S ELIZUR A
Citation: Y. Barak et al., NEUROPSYCHIATRIC ASSESSMENT AS A SECONDARY OUTCOME MEASURE IN A MULTIPLE-SCLEROSIS IVIG TRIAL, Israel journal of psychiatry and related sciences, 33(4), 1996, pp. 266-267
THE RISK OF DEVELOPING CREUTZFELDT-JAKOB-DISEASE IN SUBJECTS WITH THEPRNP GENE CODON-200 POINT MUTATION
Authors: CHAPMAN J BENISRAEL J GOLDHAMMER Y KORCZYN AD
Citation: J. Chapman et al., THE RISK OF DEVELOPING CREUTZFELDT-JAKOB-DISEASE IN SUBJECTS WITH THEPRNP GENE CODON-200 POINT MUTATION, Neurology, 44(9), 1994, pp. 1683-1686
AN ISRAELI FAMILY WITH GERSTMANN-STRAUSSLER-SCHEINKER DISEASE MANIFESTING THE CODON-102 MUTATION IN THE PRION PROTEIN GENE
Authors: GOLDHAMMER Y GABIZON R MEINER Z SADEH M
Citation: Y. Goldhammer et al., AN ISRAELI FAMILY WITH GERSTMANN-STRAUSSLER-SCHEINKER DISEASE MANIFESTING THE CODON-102 MUTATION IN THE PRION PROTEIN GENE, Neurology, 43(12), 1993, pp. 2718-2719
Risultati: 1-7 |